AM. Notice is given to the shareholders of Elisa Corporation (the "Company") of the Annual General Meeting to be held on Wedne ...

KONE Corporation, stock exchange release, January 30, 2025 at 08:00 p.m. EET. KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10. KONE C ...

On 30 January 2025, the Board of Directors of Oma Savings Bank Plc (OmaSp or the Company) has reorganised in terms of the Vice Chairperson and the Committees. The Board of Directors has elected Carl ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET . Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antib ...

Wärtsilä Corporation, Stock exchange release, 30 January 2025 at 16:00 EET. Proposals of the Shareholders' Nomination Board to Wärtsilä's Annual General Meeting 2025. The Shar ...

SPEE3D, a leading metal additive manufacturing company, announced it has sold a WARPSPEE3D printer to Northeastern University and the school's Kostas Research Institute (KRI) in Burlington, ...

Standard Lithium Ltd. (“Standard Lithium”) (TSXV:SLI) (NYSE:A:SLI), a leading near-commercial lithium developer, and Equinor, a global energy leader, today announced Smackover Lithium as the new name ...

On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river blindness. The Mectizan ...

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the pricing of a public offering of an ...

Nokia Corporation Stock Exchange Release 30 January 2025 at 8:10 EET. Proposals by the Board of Directors to Nokia Corporation’s Annual General Meeting 2025 Nokia Corporation’ ...

On 31 December 2024 Nordea Bank Abp's distributable earnings, including profit for the financial year and after subtracting capitalised development expenses, were EUR 20,871m, and other unrestricted ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...